Find all the news Pharmapar, blog entries, and all events.


  • Valtrex regains its patent right
    Valtrex regains its patent right

    Valtrex regains its patent right Pharmapar wants to inform you that the pharmaceutical company Glaxo Smith Kline regained its patent right on Valtrex (Dom-Valacyclovir).

    Published on June 9, 2014 | Category Product launch

Customer Service: 1-866-831-2003



Cart

Item Quantity Availability Price

Total: $0

Change my delivery address and billing
Continue shopping

Pharmacist area

Forgot your password?

Not listed yet?

Create now your account to place your order online.

REGISTRATION